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(57) ABSTRACT 
A method of synthesizing a heteroleptic, multiple metal 
containing metallocyclic catalyst, particularly Suited for 
asymmetric catalysis, comprising combining a plurality of 
plural functional group-containing, monodentate ligands of 
complementary chirality, said plural functional groups being 
tethered to each other by tethers in the presence of a scaffold 
structural metal Ms orderivative thereof, wherein at least one 
functional group on each ligand combines to ligate M to form 
a bidentate, M. centered ligand scaffold containing the 
remaining functional groups and combining said bidentate 
ligandscaffold with a catalytic metal Morderivative thereof 
whereby the remaining functional groups combine to ligate 
M, thereby forming said catalyst. 
18 Claims, 12 Drawing Sheets 
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1. 
SELF-ASSEMBLED HETEROLEPTC 
CHIRAL LIGANDS,ASYMMETRIC 
CATALYST SYSTEMIS AND METHODS 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims the benefit of priority of Provi 
sional Application Ser. No. 60/638,760 filed Dec. 23, 2004. 
This invention was made with Government support under 
N00014-05-1-0527 awarded by the Navy/ONR and under 
GM070939 awarded by the National Institute of Health. The 
Government has certain rights in the invention. 
FIELD OF THE INVENTION 
The invention relates to novel catalysts and catalysis reac 
tions employing same. 
BACKGROUND OF THE INVENTION 
Catalysis and asymmetric catalysis are processes of com 
mercial importance in synthetic chemistry. The development 
of efficient methods to enable the reliable, stereocontrolled 
synthesis of Small molecule target structures is an important 
goal relevant to the synthesis of compounds of commercial 
interest Such as pharmaceutical drugs, agrochemicals and 
compounds with interesting materials properties. Asymmet 
ric catalysis plays an important role in meeting this goal, and 
while tremendous advances have been realized in this rapidly 
moving field of research, significant problems remain. 
Among the most important of these problems are the need for 
(i) better substrate generality and/or more precisely substrate 
tunable catalyst systems, (ii) better catalyst stability (i.e., 
higher turnover number, TON), and (iii) better catalyst effi 
ciency (i.e., higher turnover frequency, TOF). Solutions to 
these problems hinge on discovering and optimizing new 
ligands and catalyst Systems, and understanding the reasons 
for their effectiveness. Most modular approaches start with 
one or a Small set of scaffolds (equivalently, backbones or 
templates) and sequentially append the plural ligating Sub 
stituents. The idea is to systematically vary the nature of the 
ligating groups (i.e., vary their elemental identity, shape, 
steric demand, and electronic character) to tune or optimize 
the asymmetric environment at the site of catalysis as well as 
define the nature of the metal-ligand interaction. 
An interesting scaffold is selected and one sequentially 
couples a series of ligating Substituents in ligand diversifica 
tion steps. The ligands are then evaluated in the reaction(s) of 
interest. This linear synthetic approach employed with this 
strategy has worked well; however, the necessity for prepar 
ing as few as 20-25 chiral ligands using this approach greatly 
reduces the efficiency thereof. Limitations such as these 
demand new approaches to the problem. 
For example, metal-directed self-assembly has been a very 
active area of research over the past decade and as a result 
facile routes to a wide variety of multiple metal containing 
metallocycles and metallocages have been defined Holliday, 
B. J.; Mirkin, C. A “Strategies for the construction of 
Supramolecular compounds through coordination chemis 
try.” Angew. Chem. Int. Ed. 2001, 40, 2022-2043; Leininger, 
S.; Olenyuk, B.; Stang, P. J. “Self-Assembly of Discrete 
Cyclic Nanostructures Mediated by Transition Metals.” 
Chem. Rev. 2000, 100,853-907). The potential for novel uses 
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2 
of such structures has long been the goal of the research in this 
area, but to date, the preparation of functional structures is 
still rather rare Yoshizawa, M.; Takeyama, Y.; Kusukawa, T.; 
Fujita, M. “Cavity-directed, highly stereoselective 2+2 pho 
todimerization of olefins within self-assembled coordination 
cages.” Angew. Chem. Int. Ed. 2002.41.1347-1349. 
Recently, several reports have appeared wherein self-assem 
bly is used to generate novel bidentate ligands Larsen, J.; 
Rasmussen, B. S.; Hazell, R. G.; Skrydstrup, T. "Preparation 
of a novel diphosphine-palladium macrocyclic complex pos 
sessing a molecular recognition site. Oxidative addition stud 
ies. Chem. Commun. (Cambridge) 2004, 202-203: Braun 
stein, P.; Clerc. G.; Morise, X. “Cyclopropanation and Diels 
Alder reactions catalyzed by the first heterobimetallic 
complexes with bridging phosphinooxazoline ligands. New 
J. Chem. 2003, 27, 68-72; Braunstein, P.; Clerc, G.; Morise, 
X. Welter, R.; Mantovani, G. “Phosphinooxazolines as 
assembling ligands in heterometallic complexes. Dalton 
Transactions 2003, 1601-1605; Breit, B.: Seiche, W. “Hydro 
gen Bonding as a Construction Element for Bidentate Donor 
Ligands in Homogeneous Catalysis: Regioselective Hydro 
formylation of Terminal Alkenes.J. Am. Chem. Soc. 2003, 
125,6608-6609; Siagt, V. F.; Van Leeuwen, P. W. N. M.; Reek, 
J. N. H. "Bidentate Ligands Formed by Self Assembly.” 
Chem. Commun. (Cambridge) 2003.2474-2475; Hua, J.; Un, 
W. “Chiral Metallacyclophanes: Self-Assembly, Character 
ization, and Application in Asymmetric Catalysis.” Org. Lett. 
2004, 6, 861-864: Jiang, H.; Hu, A: Un, W. “A chiral metal 
lacyclophane for asymmetric catalysis. Chem. Commun. 
(Cambridge) 2003, 96-97; Lee, S.J.; Hu, A.; Un, W. “The 
First Chiral Organometallic Triangle for Asymmetric Cataly 
sis,” J. Am. Chem. Soc. 2002, 124,12948-12949 and catalyst 
systems Gianneschi, N. C.; Bertin, P. A.; Nguyen, S. T.; 
Mirkin, C. A. Zakharov, L. N.; Rheingold, AL. “A Supramo 
lecular Approach to an Allosteric Catalyst.” J. Am. Chem. Soc. 
2003, 125, 10508-10509; Mikami, K. Tereda, M.: Korenaga, 
T.: Matsumoto.Y.; Ueki, M.; Angeluad, R. “Asymmetric acti 
vation.” Angew. Chem. Int. Ed. 2000, 39, 3532-3556; 
Mikami, K., Matsukawa, S.; Volk, T.: Terada, M. "Self-as 
sembly of several components into a highly enantioselective 
Ti catalyst for carbonyl-ene reactions. Angew. Chem., Int. 
Ed. Engl. 1998, 36, 2768-2771. The general approach 
employed is outlined in FIG.1. A metal-containing (or mul 
tiple metal-containing) scaffold is synthesized and combined 
with two or more bifunctional subunits leading to formation 
of the self-assembled ligand (SAL) 1. In general, the ligands 
prepared via this approach are symmetric since the ligating 
groups incorporated are identical; i.e., homoleptic complexes 
(i.e., two identical ligating groups) are formed. Several 
research-groups recently described Successful efforts to pre 
pare chiral SALs for asymmetric catalysis via the above 
described metal-directed self-assembly. 
It is an object of the invention to provide novel asymmetric 
catalysts prepared by a novel combinatorial method. 
It is a further object to provide novel catalyst systems 
containing the novel asymmetric catalysts. 
It is a still further object of the invention to provide novel 
catalysis methods employing the novel asymmetric catalysts 
and catalyst systems of the invention. 
SUMMARY OF THE INVENTION 
The above and other objects are realized by the present 
invention, one embodiment of which relates to a method of 
synthesizing a heteroleptic, multiple metal-containing metal 
locyclic catalyst, particularly Suited for asymmetric catalysis, 
comprising combining a plurality of plural functional group 
US 7,847,114 B2 
3 
containing, monodentate ligands of complementary chirality, 
the plural functional groups being tethered to each other by 
tethers in the presence of a scaffold-structural metal Ms or 
derivative thereof, wherein at least one functional group on 
each ligand combines to ligate M to form a bidentate, M. 
centered ligand scaffold containing the remaining functional 
groups and combining the bidentate ligand scaffold with a 
catalytic metal M or derivative thereof whereby the remain 
ing functional groups combine to ligate M, thereby forming 
said catalyst. 
A further embodiment of the invention concerns a method 
of synthesizing a heteroleptic, multiple metal-containing 
metallocyclic catalyst, particularly Suited for asymmetric 
catalysis, comprising combining, in the presence of a scaf 
fold-structural metal Ms or a derivative thereof, plural bi 
functional group-containing, monodentate ligands of 
complementary chirality having the formulae: 
1. 
LR 
and 
L2 
2 
LS 
2 N 
T2 
7 
wherein: the LS are ligating functional groups of comple 
mentary chiralty capable of ligating a scaffold-structural 
metal M, the LS are ligating functional groups capable 
of ligating a catalytic metal M and T are tethers 
linking said LS to said LS, to form a bidentate, M 
centered ligand Scaffold having the formula: 
-S- 
Ms. 1 'N 
LR LS , and 
L2 L2 
combining the bidentate ligandscaffold with a catalytic metal 
M or derivative thereof whereby the remaining functional 
groups, L combine to ligate M, thereby forming the catalyst 
having the formula: 
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Additional embodiments of the invention comprise the 
asymmetric catalysts formed by the above-described meth 
ods. 
Still further embodiments of the invention concern catalyst 
systems comprising the above asymmetric catalysts Sup 
ported on Suitable Substrates for use in catalysis methods. 
More embodiments of the invention relate to chemical 
catalysis methods employing the above described asymmet 
ric catalysts and catalyst systems. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIGS. 1-4, 6-12 set forth reaction schemes for various of 
the methods described herein. 
FIGS. 5 and 16 set forth analytical data for various of the 
compounds described herein. 
FIGS. 13-15 set forth Structural formulae for various of the 
compounds described herein. 
DETAILED DESCRIPTION OF THE INVENTION 
The present invention is predicated on the discovery of a 
method ofusing metal-directed multi-component self-assem 
bly in a new combinatorial approach to the design and opti 
mization of ligands and catalyst systems. The modular biden 
tate ligand design of the invention is based on the Scientific 
hypothesis that the nature of the ligating group can be used to 
define a chiral surface and the electronic nature of the metal 
ligand interaction, and that, then, the ligand scaffold can be 
varied through combinatorial synthesis to define the optimal 
orientation of that chiral Surface (ligating group) for efficient 
asymmetric catalysis. 
Ultimately, the goal of all chiral ligand designs is to (i) 
create an appropriate "chiral pocket around the metal to 
direct stereochemistry, and (ii) impart the appropriate elec 
tronic characteristics at the metal centerfor efficient catalysis. 
The present invention achieves these goals utilizing a conver 
gent approach to ligand Scaffold optimization using metal 
directed multi-component self-assembly. Multi-component 
reactions have garnered much attention as Synthetic strategies 
due to their potential to increase diversity while simplifying 
the synthesis of structurally complex compounds. Multi 
component self-assembly offers the same potential benefits in 
ligand synthesis of the present invention. 
The method of the invention comprises three basic steps 
(FIG. 2). One of the novel aspects of the invention resides in 
the fact that the ligandscaffold is established in the last step of 
the synthesis. The first two steps parallel that of the typical 
modular approach, except that they are applied to separate 
halves of the ultimate bidentate ligand: (i) selecting the series 
of tether subunits begins to define the scaffold and (ii) select 
ing the series of ligating groups begins to define both the 
nature of the metalligand interaction and the topology around 
the catalytic metal. The third step, the convergent self-assem 
US 7,847,114 B2 
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bly, connects bifunctional ligands to fully establish both the 
scaffold as well as the precise combination of ligating groups 
in self-assembled ligand (SAL) 9. The inventive method is 
based upon forming a heteroleptic metal complex and can be 
carried out in a combinatorial fashion. Self-assembly leaves a 
second set of ligating groups now suitably disposed to bind a 
second metal. Addition of that catalytic metal (Me) completes 
the bimetallic catalyst 10. Other modular ligand designs 
attach ligating groups as Substituents to a preformed scaffold. 
Here, metal-directed self-assembly generates the scaffold as 
the final step, and as such, allows the rapid assembly of a 
diverse set of scaffolds and more thoroughly optimize its 
Structure. 
The heteroleptic self-assembly approach of the invention is 
fundamentally different from the modular approach of the 
prior art and provides a powerful approach to the construction 
of novelligand libraries. The design concept of the invention 
is illustrated in more detail in FIG.3. To execute the approach, 
a simple, efficient, and mild method was designed for the 
metal-directed heteroleptic self-assembly via the selective 
Zinc(II)-complexation of bisoxazoline (box) subunits of 
complementary chirality. The box-tethered chiral monoden 
tate ligands 11 were used as the bifunctional ligands. Two 
independent bifunctional ligands bearing box subunits of 
opposite chirality self-assemble upon treatment with 
Zn(OAc) to give a neutral complex, a chiral bidentate SAL 
12. Each independent half in this convergent route is in turn 
prepared from three modules, (i) an (R) or (S)-box subunit; 
(ii) a tether subunit; and (iii) a ligating group. As exemplified 
below, the latteris introduced in the penultimate or a late stage 
step of the synthesis, with combinatorial zinc-directed self 
assembly as the final step. Thus, there exists the capacity for 
extensive diversification in the last two steps of the synthesis 
with self-assembly establishing both the final structure of the 
ligand scaffold and the exact combination of ligating groups 
in a SAL library. Structure 14 (discussed in detail below) 
illustrates how the concept of the invention is reduced to 
practice. 
It is known that metalloenzymes often use two types of 
metals to carry out their function. 
Structural metals help generate the three-dimensional 
structure, and a second metal binding site is often part of that 
structure. An independent, catalytic metal binds to this latter 
site to carry out the required chemistry. The system of the 
invention mimics that strategy. A neutral, heteroleptic (box) 
Zn complex, wherein the Zinc serves as a structural metal. At 
the same time, the process of self-assembly constructs a chiral 
binding site for a second, independent metal to bind and effect 
catalysis. 
Any suitable metal or combination of metals may be 
employed in the practice of the invention, including, for 
example, Zn, Co., Rh, Mg, Ca, Ba, Ti, Zr, and the like. 
Also, any suitable ligating group may be employed in the 
practice of the invention, including but not limited to those 
exemplified herein. Suitable tethering groups also include, 
but are not limited to, those exemplified below. Preferred 
tethers are alkyl (e.g., Substituted alkane and cycloalkane) 
and aryl (e.g., Substituted phenyl and biphenyl) groups. 
The self-assembled chiral catalysts and catalyst systems of 
the invention may be employed in any chemical process cata 
lyzed by any ligated metal catalyst, including, but not limited 
to, those exemplified herein as well as rhodium- and iridium 
catalyzed asymmetric hydrogenation of alkenes; rhodium-, 
iridium-, and ruthenium-catalyzed transfer hydrogenation of 
alkenes, carbonyls and imines; rhodium-, iridium-, and ruthe 
nium-catalyzed dehydrogenation of alcohols; rhodium- and 
iridium-catalyzed asymmetric hydroboration of alkenes; pal 
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6 
ladium-catalyzed asymmetric allylic alkylation and amina 
tions; palladium-, rhodium-, and iridium-catalyzed asymmet 
ric enyne cycloisomerizations; palladium-, rhodium-, and 
iridium-catalyzed asymmetric cyclizations and cycloisomer 
izations; rhodium-catalyzed alkene hydroformylation; and 
the like. 
The need to carry out efficientenantioselective catalysis is 
frequently encountered, for example, in chemical discovery 
and process research (such as commonly encountered in the 
synthesis of pharmacuticals and pharmaceutical intermedi 
ates), and for each particular Substrate, the typical approach is 
to screen a series of chiral ligands looking for the most Suit 
able catalyst system. The present invention, embodying the 
use of SALS introduces a new paradigm for chiral catalyst 
development, develops a niche for custom asymmetric cata 
lysts, for example, for asymmetric allylic amination, asym 
metric hydrogenation, and asymmetric hydroboration. More 
over, the chiral ligand libraries (exemplified below) produced 
also find applications in numerous other metal-catalyzed 
reactions, provided, of course, that the reactions do not 
require the use of reagents that have deleterious effects on the 
catalysts. 
Those skilled in the art will realize that the SAL concept 
described herein may be extended from one that focuses 
exclusively on the design of chiral bidentate ligands to 
include polydentate ligands, for example, tri- or tetradentate 
ligands. One box derivative will contribute abidentate ligand 
upon self-assembly, the other a mono- orbidentate ligand as 
needed, for example, the development of polydentate chiral 
SALs, particularly for expanding the chiral ligand systems for 
lanthanide catalysis. The invention is also applicable for 
developing bifunctional catalysts systems, reversible reagent 
delivery, and sequenced multi-component reactions; indeed, 
virtually any combinatorial chemical synthesis. 
EXAMPLE 1. 
Referring to FIG.4, the neutral, homochiral complex (R.R- 
17) is formed by stirring two equivalents of (4R,4R)-15 with 
Zn(OAc). Zn(OAc) serves a dual role in the reaction, simul 
taneously delivering the metal center and the required base. 
However, when a racemic mixture of box ligands (i.e., one 
equivalent each of (4S.4'S)-15 and (4R,4'R)-15) is combined 
with Zn(OAc), three complexes could theoretically form, the 
homochiral complexes (S,S)—and (R,R)-17 (i.e., chiral self 
recognition) and the heterochiral complex (S,R)-16 (i.e., 
chiral self-discrimination). The tetrahedral coordination 
geometry of Zinc(II) strongly favors self-discrimination in 
this case. Indeed, only the neutral, heterochiral complex 
(S,R)-16 is observed. 
EXAMPLE 2 
FIG. 5 compares the 1H NMR spectrum for the free box 
ligand 15 (tracea) to those of the heterochiral ((S,R)-16, trace 
b) and homochiral complexes ((R,R)-17, trace c). These spec 
tra show that the homochiral and heterochiral complexes are 
distinctly different in solution, and to the level of NMR detec 
tion, the combination of (4S.4'S)-15 and (4R,4'R)-15 with 
Zn(OAc) affords exclusively the heterochiral complex. Of 
particular note in the spectrum of (S,R)-16 is the dramatic 
upfield shift for the hydrogen on the phenyl-bearing carbon of 
the dihydrooxazole ring (H"; see structure 15, FIG. 4). It is 
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highly shielded in the heterochiral complex relative to the free 
ligand or homochiral complex. 
EXAMPLE 3 
To better understand the factors favoring self-discrimina 
tion over self-recognition, crystals of (S,R)-16 and (S,S)-17 
were grown and their structures determined by X-ray analysis 
(FIG. 6). The heterochiral complex (S,R)-16 exhibits near 
perfect tetrahedral coordination while the homochiral com 
plex (S,S)-17, for which there are two closely related con 
formers in the unit cell, distorts from tetrahedral coordination 
to minimize steric interactions between the phenyl substitu 
ents of the two box ligands. Otherwise, the bond lengths and 
angles vary little between the two complexes. The crystal 
structures are consistent with the NMR data, particularly the 
positioning of the phenyl groups in the heterochiral complex 
(S,R)-16 so as to shield the hydrogen on the phenyl-bearing 
carbon of the dihydrooxazole ring (H). 
EXAMPLE 4 
Heterochiral complexes such as (S,R)-16 are meso by 
inversion symmetry and hence achiral. Nevertheless, the pro 
cess of chiral self-discrimination is inherently one of hetero 
leptic self-assembly (i.e., non-identical groups bond to the 
metal) and is not restricted to combining pairs ofenantiomers. 
Pseudo-enantiomers can combine similarly to afford prod 
ucts lacking a center of inversion. To illustrate this and the 
potential versatility for preparing chiral, heteroleptic com 
plexes, the pseudo-racemic combination (4S.4'S)-18 and (4R, 
4R)-19 was used to prepare the mixed cyano/benzyl-substi 
tuted complex 20 (FIG. 7). In spite of the complementary 
chirality of the box moieties, complex 20 lacks inversion 
symmetry and is chiral, exhibiting a large optical rotation, 
C-203° (c=0.75, CHCl). 
EXAMPLE 5 
The neutral Zinc complexes prove to be quite remarkable 
compounds. Complexation is reversible in the presence of a 
proton Source, for example, adding another (R)- or (S)-box 
derivative leads to rapid substitution, and mixing equal 
amounts of the enantiomeric homochiral complexes 17 leads 
to their rapid disproportionation (FIG. 6). Complete conver 
sion to the heterochiral complex (R.S)-16 as judged by 1H 
NMR again indicates that the heterochiral complex is the 
thermodynamic sink. The neutral metal complexes are typi 
cally freely soluble in a variety of organic solvents (e.g., 
toluene, CHC1, CHCl, THF, dioxane, and acetonitrile) and 
partially soluble in methanol. They are generally insoluble in 
hexanes, diethyl ether or cold methanol, and these latter 
organic solvents can be used to precipitate the complex from 
other solvents and/or wash the precipitated complex. It was 
Surprising to find that, in some cases, the complexescan be 
subjected to column chromatography on silica (1% MeOH in 
CHCl eluent) with little or no loss of zinc. Complex 16 is 
insoluble, but stable toward water, and can be subjected to 
extractive workup. Drying the organic phase with anhydrous 
Na2SO does not affect metal exchange. The complex is not 
completely inert toward protic solvents. For example, adding 
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CDOD to a solution of (S,R)-16 (CDCI) shows complete 
H/D exchange by the time the 1H NMR spectrum is recorded. 
EXAMPLE 6 
The facile formation of a heterochiral complex is not lim 
ited to zinc. The corresponding heterochiral Co(II) complex 
was prepared. Its crystal structure is virtually Superimposable 
on that of the zinc structure. 
EXAMPLE 7 
Self-assembly is also not limited to methylene box sub 
strates or to the 4-phenyl-substituted box ligands illustrated. 
Corresponding complexes from 4.5-diphenyl and indanyl 
box derivatives have been prepared as well; for example, the 
crystal structure of the heterochiral (indanylbox)Zn complex 
21 is shown above (FIG. 7). 
EXAMPLE 8 
It was found that the heterochiral (box)Zn complex, once 
formed, is stable toward exchange with several common 
ligands (e.g., 2.2-isopropylidenebis(4-phenyl-2-oxazline), 
PhP BINAP, BINOL and diethyl tartrate). Furthermore, sev 
eral potential ligands (i.e., 2,2'-isopropylidenebis(4-phenyl 
2-oxazline), PhP CY3P. dppe) were tested in direct compe 
tition and do not to interfere with formation of the 
heterochiral complex. Their chemical characteristics, the 
structural Studies, and their self-sorting and stability tests 
gave confidence that neutral, heterochiral (box)Zn com 
plexes would remain intact and could be used in the presence 
of other Suitable ligands. Their preparation is simple: mix the 
two enantiomeric box derivatives with Zn(OAch, remove the 
solvent (CH.Cl/MeOH), triturate with methanol, and wash 
the resulting solid with methanol. The synthetic yields are 
high (typically 70-90%), and examination of the crude prod 
uct reveals no side products. Mechanical losses probably 
account for the less than perfect isolated yields obtained. 
EXAMPLE 9 
To get a better idea of the tether structure that would be 
needed to realize the approach in FIGS. 7 and 8 the hetero 
chiral (benzylBox)Zncomplex 22 (FIG. 8) was prepared and 
crystallized. By analysis of its crystal structure, and from 
manipulating that structure in Chem3D, it is apparent that the 
appended benzyl groups are of Sufficient length to extend 
beyond the bulk of the (boxh)2Zn core, i.e., the benzyl groups 
can freely rotate and extend beyond the metal complex core. 
In fact, the core is quite compact; its end-to-end length is a 
little shorter than that of biphenyl. It was reasoned that sub 
stituted benzyl or biphenyl tethers should extend a tethered 
ligating group beyond the core and permit chelation as 
depicted schematically in FIGS. 7 and 8. The complex is also 
inherently a rather rigid structural element, contrary to what 
might be predicted. There is only one rotational degree of 
freedom relating the positions of the two benzyl substituents 
(i.e., would be tethers), two independent rotatable bonds but 
since they lie along the same axis it introduces a just single 
rotational degree of freedom. 
EXAMPLE 10 
In light of the crystal structure of 22 and with an eye toward 
keeping the tether subunits relatively rigid, a series of substi 
tuted benzyl and biphenyl tethers was focused on for prepar 
US 7,847,114 B2 
ing SALS (FIG. 9). The synthetic route is illustrated for the 
preparation of 24F.The key step is mono-alkylation of the box 
subunit with a substituted benzyl bromide bearing a pendant 
silyl-protected hydroxyl substituent. For these initial studies, 
the derivative was prepared bearing a pendant TADDOL 
derived monophosphite. Deprotection of the silyl ether fol 
lowed by coupling with (R,R)-TADDOL)PCI affords the 
desired bifunctional box-(TADDOL)phosphite conjugate 
24F. The six step synthesis is quite efficient, and, typically 
5-10 mmol of the penultimate intermediate, the alcohol 23, is 
prepared. 
EXAMPLE 11 
Treating the combination of (S,S)-24F and (R,R)-24F with 
Zn(Oac) affords the pseudo-C2-symmetric complex 25FF 
(FIG. 10). The reaction is carried out by mixing the two 
diastereomeric bifunctional ligands (24F) with Zn(Oac), 
removing the solvent (CH2Cl2/MeOH), triturating with 
methanol, and washing the resulting Solid with methanol. The 
following data Support its structural assignment. (1) The two 
diastereomeric bifunctional ligands (24F) are freely soluble 
in methanol, 25FF is not; the recovery of 25FF is high (79%). 
(2) The optical rotation of 25FF is lower than either of the 24F 
diastereomers. (3) 25FF melts with decomposition at a tem 
perature 25-30 degrees higher than the melting points of the 
24F diastereomers. (4) The HRMS matches for the parention 
of 25FF: the experimental and simulated isotope distribution 
patterns match. (5) The I H and 13C NMR spectra are con 
sistent with an overall pseudo-C-symmetric structure and 
show the expected elements in common 22, the dibenzyl box 
model compound for which the crystal structure is known. (6) 
The 31p NMR spectrum of 25FF shows a single resonance at 
130.2 ppm, similar to that of its precursor (S,S)-24F (130.7 
ppm). 
EXAMPLE 12 
Having formed 25FF, the crucial question is whether the 
pendant phosphites can coordinate a second metal. To test 
this, 25FF was treated with an equivalent of (cod), RhBF. 
The 'P NMR signal at 130.2 ppm, characteristic of a free 
phosphite, is lost and a new doublet appears at 112.7 ppm 
(J-248.6 Hz). The results are consistent with the forma 
tion of the chiral heterobimetallic rhodium complex (cod)Rh 
(25FF)|BF (26). Demonstrating that SAL 25FF forms a 
rhodium(I) complex is of particular relevance to, for example, 
(SAL)RhX-catalyzed asymmetric hydroboration reactions. 
EXAMPLE 13 
The selective formation of the heteroleptic (box)Zn com 
plex is driven by the complementary chirality of the box 
subunits and is essentially independent of the nature of the 
remote substituents on each box ligand. A series of bifunc 
tional ligands 24A-M were prepared (FIG. 11). For the pur 
poses of this initial study the ligating group was kept constant, 
the choice of the TADDOL-derived monophosphite ligating 
group was more or less arbitrary. Treating complementary 
combinations of bifunctionalligands 24A-M with Zn(OAch 
is a simple way to prepare a library of SALs 25XY. We 
prepared 50 of the 169 possible combinations of subunits 
24A-M. Each SAL 25XY bears two pendant TADDOL-de 
rived monophosphites, thus the shape and electronic charac 
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teristics of the ligating groups are constant in this ligand 
library; only the ligand scaffold is varied. The idea was to 
determine whether the structure of the scaffold alone is suf 
ficient to control the level of asymmetric induction exhibited 
by the derived catalyst systems. The SALs were screened in 
the palladium-catalyzed asymmetric allylic amination of 
racemic carbonate 27 by N-methyl-p-toluenesulfonamide. 
Chiral diphosphites have been employed in a wide range of 
asymmetric reactions, including palladium-catalyzed allyla 
tions; the latter are frequently used as a testing ground for new 
chiral ligand motifs. For reference, the corresponding allylic 
amination using two equivalents of ((R,R)-TADDOL)POPh 
(29, i.e., the same chiral ligating group without the SAL) 
gives (R)-28 (R-Me) in 48% ee. 
The chiral diphosphites screened differ only in the struc 
ture of the self-assembled ligand scaffold, and while each 
gives predominantly (R)-28 (R-Me), the variation in enanti 
oselectivity is striking. Plotting the results obtained for the 50 
combinations of subunits A-Min descending order (FIG. 11), 
it can be seen that the enantiomeric excess varies almost 
linearly over a wide range (i.e., 20-97% ee). Two thirds of the 
SALS screened give a higher level of asymmetric induction 
than the monomer (R,R)-TADDOL)POPh. While the goal, 
of course, is to obtain enantiomerically pure material directly 
from the reaction, products obtained at the level of 90% ee 
(95:5 er) are often practical; they can often be enriched to 
enantiomeric purity via one recrystallization with minimal 
losses. Nine combinations of SAL 25XY effect the asymmet 
ricallylation in 90% ee or higher. 
The variation in enantiomeric excess demonstrates the 
ability to use very Subtle changes in the scaffold to manipulate 
the ligand topography around palladium. As tabulated in 
Table 1 each of the top catalysts contains one of two closely 
related subunits, F or H. These two tethers differ only in 
regard to the Substitution pattern (1.3- VS. 1.4-) on the phenyl 
ring closest to the box subunit. The most Successful ligand, 
25FH, contains both subunits and affords 28 (R-Me) in 97% 
ee (entry 1). Surprisingly, the pseudo-C2-symmetric deriva 
tives 25FF and 25HHare less effective, giving 84% and 87% 
ee respectively (entries 11 and 12). Compared to the latter 
two, the combinations 25FG and 25GH (entries 8 and 10; 
90% and 87% ee) are similar to, perhaps slightly superior, and 
yet, 25GG is one of the worst combinations (entry 50.20% 
ee). The presence of For H in and of itself does not guarantee 
success; 25AF is another of the worst combinations (entry 49, 
20% ee). It is interesting to see that two poor subunits can 
form a favorable combination. Neither 25AA (60% ee) nor 
25KK (31% ee) are very good, but the combination 24AK at 
75% ee is the best SAL lacking eitheran For H subunit. When 
the substrate is changed, even modestly, SAL 25FH is no 
longer always the best choice. This highlights another feature 
of the self-assembly approach of the invention: easy ligand 
tunability. Chiral diphosphites 25FF, 25FH, and 25HH were 
screened with four other N-substituted sulfonamides giving 
the allylation product in high enantiomeric excess, for 
example (results for best SAL shown), N-(n-butyl) (25FF, 
90% ee), -benzyl (25FH, 91% ee), -isopropyl (25HH, 95% 
ee), and -phenyl (25FF, 88% ee). 
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TABLE 1. 
Data Summary Table 1. Screening SALS 25XY in the palladium 
catalyzed allylic amination reaction with TsN(H)Me. 
(TDO)2P-X 
A (X = O) 
B (X= OCH) 
(TDO)P-X 
X 
M (TDO)2P 
C (X = O) 
D (X = OCH2) E (X = O) 
F (X = OCH) 
X X 
M W (TDO)2P (TDO)2P 
G (X = O) I(X = O) 
H(X = OCH) J (X = OCH2) 
(TDO)2P-X . 
K (X = O) (TDO)P-O 
L (X = OCH2) 
M 
SAL % ee 
1 FH 97 
2 FM 94 
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TABLE 1-continued 
Data Summary Table 1. Screening SALS 25XY in the palladium 
catalyzed allylic amination reaction with TsN(H)Me. 
3 FJ 93 
4 H 93 
5 EH 92 
6 FL 92 
7 HL 92 
8 GH 90 
9 HM 90 
10 FG 87 
11 HH 87 
12 84 
13 EF 8O 
14 FI 8O 
15 HK 78 
16 FK 77 
17 AK 75 
18 AH 75 
19 75 
2O M 72 
21 71 
22 CF 67 
23 K 67 
24 CH 63 
25 E 62 
26 AA 60 
27 CC 60 
28 CK 55 
29 G S4 
30 M S4 
31 MM S4 
32 J 51 
33 AC 50 
34 C 47 
35 K 47 
36 L 46 
37 A. 44 
38 G 44 
39 C 43 
40 E 42 
41 BB 40 
42 L 40 
43 J 40 
44 EE 37 
45 AJ 34 
46 33 
47 KK 31 
48 DD 23 
49 AF 2O 
50 GG 2O 
EXAMPLE 1.4 
Studies on the hydroboration of styrene were carried out 
using a screening set of SALS. Two simple tethers were cho 
sen, one phenol and one benzyl amine. Prepared derivatives 
A-Hare illustrated in FIG. 12. Combinations of A-Husing the 
Zn(Oac) protocol afford a small screening set of SALS 
50XY. Some preliminary data obtained with them are sum 
marized in Table 2. Since the scaffold is not optimized at this 
stage, it was not expected to obtain the highest possible enan 
tiomeric excess. However, useful information can be obtained 
from the relative activity of the catalysts from the various 
combinations, and in the case of styrene, the regioselectivity 
(i.e., branched versus linear alcohol). To get a rough measure 
catalyst activity, each reaction was run for the same standard 
time; consequently, the observed yield is a measure of cata 
lyst turnover frequency and/or number. 
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TABLE 2 
(50XY)Rh(cod)Cl]-catalyzed hydroboration of styrene. 
The product is predominantly R. 
Entry 5OXY Yield (%) 51:52 ee (%) 
1 AA 98 2.5: 76 
2 AB 88 1.S: 2 
3 AC 90 6.1: 46 
4 AD 90 4.3: 60 
5 AE 30 1:1.3 3 
6 AH 95 6.6: 78 
7 BB 75 1: O 
8 BD 85 2: 17 
9 BF 95 4: 7 
10 BG 99 2: 14 
11 CF 8O 10: 8 
12 CG 90 15: 7 
13 CH 90 6.9: 4 
14 DD 26 1:1. 3 
15 E 50 1:2.5 4 
16 F 35 1:1-2 30 
17 GG 41 1:1. 3 
18 G 90 1:3 10 
The results in Table 2 are very encouraging. They demon 
strate that one can Successfully use SALS in this reaction, and 
as expected, the various combinations 50XY show a wide 
range of behavior: yields vary from no reaction (50H1, data 
not shown) to near quantitative (50BG, entry 10); regioselec 
tivity varies from 15:1 favoring the branched alcohol (50CG, 
entry 12) to 1:3 favoring the achiral linear isomer (50GI, entry 
18); and the enantioselectivity reaches as high as 78%. This 
means that the elements in the SAL which can be varied are 
very much involved in determining reaction selectivity. For 
example, it is particularly striking how strongly the presence 
of subunit C improves the regioselectivity toward the desired 
branched isomer. 
EXAMPLE 1.5 
Rhodium-Catalyzed Asymmetric Hydrogenation 
The need to carry out enantioselective hydrogenation is 
frequently encountered in chemical discovery and process 
research. Such processes are relevant to the production of a 
wide range of synthetic intermediates andare of Substantial 
industrial importance. There exist significant drawbacks to 
carrying out these types of reactions utilizing currently avail 
able catalyst systems. The reaction also constitutes a common 
testing ground for new ligand systems for asymmetric cataly 
sis. Having used palladium-catalyzed allylic amination to 
demonstrate proof of principle for the method of the invention 
above, asymmetric hydrogenation offers the opportunity to 
evaluate the approach with a different metal and in very 
different reaction. 
A new concept in asymmetric catalysis has previously been 
reported, i.e., the idea of screening combinatorial mixtures of 
simple monodentate ligands. In rhodium-catalyzed hydroge 
nation reactions, prior researchers found that the enantio 
meric excess obtained from certain mixtures of ligands was 
higher than that obtained with either ligand alone. 
In the SAL approach of the present invention, there exists 
considerable flexibility as to the choice of ligating groups. 
Thus, it is desirable to select the combination(s) of ligating 
groups that will most likely afford efficient catalysts (effi 
ciency as defined by yield and reaction rate as well as selec 
tivity), and then rely on the ability to vary the SAL scaffold to 
optimize their orientation and hence the enantioselectivity. To 
aid in selecting the most promising ligating group(s) for pre 
paring the SAL library, various combinations of the mono 
meric modelligands (I-X) shown in FIG. 14 were screened 
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in the rhodium-catalyzed hydrogenation of the amino acid 
precursor, enamide 7. The monomeric ligands shown corre 
spond to ligating groups that could readily be incorporated in 
the SAL precursors described above. 
TABLE 3 
O 
1% Rh(coo)2BF4 
N OMe 1.1% total Egand 
CH2Cl2, 25 psi H2, 
NHAC 10 h, rt 
7 
O 
OMe 
NHAC 
8 
(S)-IV (R)-V, VI, VII, VIII, IX (R)-X. 
In 5 5 13 10 100 10 1 
(5S) (1 S) (5 S) (7 R) (5 R) (2S) (5 S) 
In 93 99 26 100 100 90 99 
(rac) (1S) (3S) (1S) (5S) (1 R) (7 S) 
III, 68 94 55 100 100 1OO 89 
(rac) (rac) (8R) (3R) (12 S) (1S) (13 S) 
(S)-IV, 17 7 3 18 98 15 42 
(10 R) (1 S) (8 S) (33 R) (8R) (3 S) (57 S) 
(R)-V 2O 42 16 97 14 37 
(26R) (43 R) (29 R) (rac) (3S) (61 S) 
VI, 5 14 24 3 19 
(4 S) (6 S) (2R) (10 R) (43 S) 
VII, 24 100 19 98 
(34R) (4R) (4 S) (57 S) 
VIII, 100 1OO 1OO 
(11 R) (4R) (rac) 
IX. 1OO 1OO 
(2S) (76S) 
(R)-X. 1OO 
(65 S) 
"The table entries refer the combination of ligands (0.55 mole percent of each) used for that 
reaction; the chemical yields are shown along with the 96 ee's obtained and the major 
enantiomer formed given in parentheses, For example, data in the first row show the results 
obtained using the combination of 0.55 mole percent of ligand I with 0.55 mole percent of 
each of the chiral monomeric ligandsV. through *X, 
The tabulated screening data (Table 3) provide a great deal 
of information. The goal of the study is not to necessarily 
identify the optimal monodentate ligand for the reaction; 
others have successfully pursued that approach as described 
above. Rather, the purpose is to identify promising ligating 
groups that can readily be incorporated into SAL precursors 
to prepare SAL libraries with which the potential for ligand 
tuning via scaffold optimization can be evaluated. The vari 
ous combinations of ligands I-X, give rise to wide varia 
tions in yield and enantioselectivity in the rhodium-catalyzed 
asymmetric hydrogenation of enamide 7. The axially chiral 
BIPHEP phosphite derivative X, stands out as the most 
interesting ligandscreened. Almost every combination with it 
gives an appreciable level of enantioselectivity. Its hetero 
combination with the TADDOLderivative “IX, is particu 
larly intriguing. Considering the data in Table 1, the BIPHEP 
phosphite ligating group appears to be the obvious lead struc 
ture for an initial SAL library. 
Investigating a combinatorial library of (R)BIPHEP-SALs 
involved the preparation and screening of a library of 110 
SAL combinations (i.e., SAL-9XY) in the rhodium-catalyzed 
hydrogenation of the amino acid precursor, enamide 7. The 
SALs screened were drawn from the set of subunits illustrated 
in FIG.15 (i.e., SAL subunits A-L). Each subunit contains the 
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BIPHEP phosphite ligating group, and for the most part, the 
SALs used in the (SAL9XY)Rh(BF)-catalyzed asymmet 
ric hydrogenations of enamide 7 were prepared in situ by 
combining the desired two SAL subunits with EtZn. 
FIG. 16 shows the variation in enantioselectivity obtained 
as a function of the SAL scaffold for the 110 SAL-9XY (X 
and Y independently selected from among A through L) com 
binations screened in the present study; the percent ee 
obtained is plotted from low to high. For reference, using two 
equivalents of chiral monophosphite (BIPHEP)POPh (X) 
gives 65% ee in the reaction. Once again, wide variation 
exists in enantioselectivity, from racemic to above 80% ee. 
with roughly two thirds of the SAL-9XY combinations 
affording a higher level of asymmetric induction than the 
model monomer X. The results of the screening reactions 
reflect only the influence of varying the scaffold structure; 
every SAL in the screen has the same set of BIPHEP ligating 
groups. The graph is qualitatively similar to that seen for the 
palladium-catalyzed asymmetric allylic amination reported 
above; however, unlike that study, here, the plot levels off. 
Apparently, many of the variations in Scaffold are effec 
tively redundant; that is, they do not significantly alter the 
5 
16 
topography defined by the BIPHEP phosphite moiety in the 
chiral rhodium catalyst. The results suggest that a more 
diverse set of SAL subunits is needed to further optimize the 
scaffold structure or that the limit of the capacity to produc 
tively orient the BIPHEP phosphite moiety has been reached. 
Nonetheless, the best SAL combinations identified thus far 
are already very close to giving useful levels of asymmetric 
induction. 
TABLE 4 
(SAL-9XY)Rh(BF)-Catalyzed asymmetric hydrogenation of 
dehydroaminoacid derivative 7 using 
various combinations of BIPHEP-SAL subunils A-L. 
O 
1% Rh(coo)2BF4 
N OMe 1.1% SAL-9XY 
NHAC CH2Cl2, 25 psi H2, rt 
7 
O 
OMe 
NHAC 
8 
SAL 
9XY R-A R-B R-C R-D R-E R-F R-H R-I R-J R-L 
S-A 49 66 16 78 3S 78 100 49 23 75 
(62) (79) (61) (73) (59) (75) (72) (73) (71) (69) 
S-B SO 69 7 61 26 79 97 47 46 49 
(69) (76) (58) (75) (64) (78) (81) (78) (76) (72) 
S-C S 18 3 52 2 66 35 33 24 17 
(57) (70) (58) (78) (58) (79) (43) (76) (75) (73) 
S-D 4 1 2 51 1 73 17 71 54 35 
(34) (35) (13) (79) (35) (80) (35) (79) (79) (75) 
S-E 6 11 4 24 3 43 23 47 34 27 
(41) (66) (rac) (70) (9) (75) (22) (73) (69) (65) 
S-F 13 55 7 81 9 87 42 92 90 70 
(64) (72) (59) (82) (67) (81) (45) (82) (82) (80) 
S-G 10 S4 10 60 11 35 61 31 25 45 
(62) (73) (58) (80) (69) (78) (50) (76) (76) (78) 
S-H 13 46 14 S9 6 28, 18 100 44 66 
(31) (60) (17) (74) (28) (71) (16) (76) (55) (66) 
S-I. 21 96 38 96 S8 97 94 97 82 96 
(53) (76) (76) (77) (73) (81) (54) (79) (76) (76) 
S-J 28 95 44 92 30 93 98 67 S7 37 
(65) (75) (66) (78) (67) (80) (52) (76) (78) (76) 
S-K 10 28 1 38 1 89 10 68 13 26 
(52) (70) (22) (78) (39) (82) (20) (79) (75) (75) 
The detailed results of the screening reactions are Summa 
55 
60 
65 
rized in Table 4. Again, the data demonstrate wide variation in 
both yield and enantioselectivity for the (SAL-9XY)Rh 
(BF) catalyzed asymmetric hydrogenation. While the latter 
ranges from racemic to above 80% ee, the 
S-enantiomer predominates in all non-racemic products 
obtained. Eleven combinations (i.e., those highlighted in 
boldface in Table 4) give 80% ee or greater. An interesting 
trend emerges from the data obtained with this combinatorial 
library of 110 SALs. Nine of the eleven most successful 
combinations contain subunit F., for example, the combina 
tion using two F subunits, SAL-9FF, is among the best, 
affording 81% ee (87% yield). 
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However, small changes in the SAL scaffold can result in 
large differences in enantioselectivity and yield. For example, 
contrast the results obtained using SAL-9FF (81% ee, 87% 
yield) to those obtained using the closely related structure 
SAL-9EE (9% ee.3% yield). While each of the SALs in Table 
4 is structurally unique, Some differ only very Subtly in Scaf 
fold structure. For example, SAL-9FI can be prepared by 
combining (S)-F with (R)—I or by combining (R)- F with 
(S)-1. The resulting diastereomeric SALS generally behave 
similarly, 82% ee (92% yield) and 81% ee (97% yield), 
respectively, for the two combinations described. 
The results obtained thus far make it clear that, while the 
shape of the BIPHEP-phosphite ligating group within the 
macro cyclic metal chelate is invariant, Small changes in the 
ligand Scaffold reposition or reorient that shape to a more, or 
less, effective position for asymmetric catalysis. 
Suitable ligands and tethers are exemplified above; how 
ever, it will be apparent to those skilled in the art that many 
more such groups may be employed in the practice of the 
invention and that the identification thereof would not require 
the exercise of inventive faculties. 
The invention claimed is: 
1. A heteroleptic, multiple metal-containing metallocyclic 
catalyst having the formula: 
wherein: L. and L. are each ligating functional groups of 
complementary chirality, said L. having a counter 
clockwise configuration and said L. having a clock 
wise configuration; 
wherein said M is a scaffold-structural metal and wherein 
the scaffold-structural metal is Zn(II) or Co(II): 
wherein said M is a catalytic metal and wherein the cata 
lytic metal is Rh(I), Pd(II) or Ir(I): 
wherein each of said L is a ligating functional group; 
wherein said T and T are each tethers; 
wherein each of said L. and is capable of ligating said 
M: 
wherein each of said L is capable of ligating said M. 
wherein said T links each of said L. and is connected to 
at least one of said L. and 
wherein said T links each of said L and is connected to at 
least one of said L. 
2. The catalyst of claim 1, wherein the ligating functional 
groups are (TADDOL)P (BINOL)P , or (BIPHEP)P 
derivatives, said derivatives selected from the group of deriva 
tives consisting of (TADDOL)P , (BINOL)P - or (BI 
PHEP)P phosphites: (TADDOL)P (BINOL)P or (BI 
PHEP)P - phosphoramidites: 
and (TADDOL)P (BINOL)P or (BIPHEP)P phos 
phinites. 
3. The catalyst of claim 2, wherein the ligating functional 
groups are (TADDOL)P (BIINOL)P or (BIPHEP)P 
phosphites. 
4. The catalyst of claim 2, wherein the ligating functional 
groups are (TADDOL)P , (BINOL)P or (BIPHEP)P 
phosphoramidites. 
5. The catalyst of claim 2, wherein the ligating functional 
groups are (TADDOL)P , (BINOL)P or (BIPHEP)P 
phosphinites. 
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6. The catalyst of claim 1, wherein the ligating functional 
groups are at least one of 
Air Air 
O O 
X ) P O s { 
Air Air 
(TADDOL)P- 
O V 
P 
/ 
CO 
(BINOL)P- 
O V 
P-. 
. 
7. The catalyst of claim 1, wherein the ligating functional 
groups are selected from the group consisting of (TADDOL) 
P , (BINOL)P , and (BIPHEP)P phosphites; and 
wherein the catalytic metal is selected from the group con 
sisting of Rh(I), Pd(II) and Ir(I). 
8. The catalyst of claim 1 having the formula: 
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-continued 12. The catalyst of claim 1, wherein the tethers are: 
10 
11(X = O) 15 
12(X = OCH2) 
L-X 
13. The catalyst of claim 7, wherein the scaffold-structural 
metal is Zn(II) or Co(II). 13(X = O) 
14(X = OCH2) 
14. The catalyst of claim 1, wherein the catalytic metal is 
Rh(I). 
15. The catalyst of claim 1, wherein the catalytic metal is 
35 Ir(I). 
16. The catalyst of claim 1, wherein the catalytic metal is 
Pd(II). 
40 O 17. The catalyst of claim 1, wherein the scaffold-structural 
metal is Zn(II). 
1. X 
L 18. The catalyst of claim 1, wherein the scaffold-structural 
45 metal is Co(Il). 15(X = O) 
16(X = OCH2) 
  
